Sumeet S. Mitter

ORCID: 0000-0003-4828-5191
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Mechanical Circulatory Support Devices
  • Heart Failure Treatment and Management
  • Cardiac Structural Anomalies and Repair
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Transplantation: Methods and Outcomes
  • COVID-19 Clinical Research Studies
  • Cardiac pacing and defibrillation studies
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrest and Resuscitation
  • Cardiac Imaging and Diagnostics
  • Long-Term Effects of COVID-19
  • Energy and Environment Impacts
  • Cardiovascular and Diving-Related Complications
  • Infective Endocarditis Diagnosis and Management
  • COVID-19 and healthcare impacts
  • Air Quality and Health Impacts
  • Parathyroid Disorders and Treatments
  • Diabetes Treatment and Management
  • Dialysis and Renal Disease Management
  • Cardiac Arrhythmias and Treatments
  • HIV-related health complications and treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Cardiovascular Disease and Adiposity
  • Climate Change and Health Impacts

Icahn School of Medicine at Mount Sinai
2012-2024

Alaska Heart and Vascular Institute
2024

Mount Sinai Hospital
2019-2024

Mount Sinai Health System
2024

Cardiovascular Institute of the South
2017-2023

Mount Sinai Hospital
2019-2022

Northwestern University
2015-2022

Pfizer (United States)
2021

Tehran University of Medical Sciences
2016

University of Cambridge
2016

HomeCirculation: Heart FailureVol. 13, No. 10Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19 Free AccessCase ReportPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplemental MaterialFree ReportPDF/EPUBCardiogenic Vinh Q. Chau, Gennaro Giustino, Kiran Mahmood, Estefania Oliveros, Eric Neibart, Mehdi Oloomi, Noah...

10.1161/circheartfailure.120.007485 article EN Circulation Heart Failure 2020-08-26

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with mildly preserved ejection fraction. In this study, safety and efficacy dapagliflozin according to background diuretic therapy influence on longitudinal use were evaluated.

10.1093/eurheartj/ehad283 article EN cc-by-nc European Heart Journal 2023-05-23

Tricuspid regurgitation (TR) is a common and progressive valve disease with significant mortality hospitalization burden. transcatheter edge-to-edge repair provides treatment option for high-risk patients primary secondary TR. The TRILUMINATE trial ([Trial to Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients Moderate or Greater Regurgitation]; n=85) an international, prospective, single-arm, multicenter study investigate the safety performance of tricuspid TriClip...

10.1161/circinterventions.122.012888 article EN Circulation Cardiovascular Interventions 2023-08-01

Background— Household air pollution is the third largest risk factor for global disease burden, but direct links with cardiovascular mortality are limited. This study aimed to evaluate relationship between household fuel use and mortality. Methods Results— The Golestan Cohort Study in northeastern Iran enrolled 50 045 individuals 40 75 years of age 2004 2008 collected data on lifetime other baseline exposures. Participants were followed up through 2012 a 99% successful follow-up rate. Cox...

10.1161/circulationaha.115.020288 article EN Circulation 2016-06-13

Aims In heart failure (HF) with preserved ejection fraction (HFpEF), excessive redistribution of blood volume into the central circulation leads to elevations intracardiac pressures exercise limitations. Splanchnic ablation for management (SAVM) has been proposed as a therapeutic intervention. Here we present preliminary safety and efficacy data from initial roll‐in cohort REBALANCE‐HF trial. Methods results The open‐label (roll‐in) arm will enrol up 30 patients, followed by randomized,...

10.1002/ejhf.2559 article EN cc-by-nc European Journal of Heart Failure 2022-05-22

Abstract Aims Readmission after hospitalization for acute decompensated heart failure (HF) remains a major public health problem. Use of remote dielectric sensing (ReDS) to measure lung water volume allows an objective assessment status and may guide medical optimization HF. We hypothesized that the use ReDS would lower 30 day readmission in patients referred rapid follow‐up (RFU) clinic HF discharge. Methods results conducted retrospective analysis scheduled RFU within 10 days...

10.1002/ehf2.13026 article EN cc-by-nc ESC Heart Failure 2020-12-18

OBJECTIVE: Apolipoprotein E4 may benefit children during early periods of life when the body is challenged by infection and nutritional decline.We examined whether apolipoprotein affects intestinal barrier function, thereby improving short-term growth long-term cognitive outcomes in Brazilian shantytown children. METHODS:A total 213 with below-median height-for-age z-scores (HAZ) received 200,000 IU retinol (every four months), zinc (40 mg twice weekly), or both for one year, half each group...

10.6061/clinics/2012(01)03 article EN cc-by-nc Clinics 2012-01-01

BACKGROUNDOrthotopic heart transplantation (OHT) recipients may be particularly vulnerable to coronavirus disease 2019 (COVID-19). OHT during the pandemic presents unique challenges in terms of feasibility and safety.METHODSChart review was performed for consecutive with COVID-19 waitlisted patients who underwent from March 1, 2020 May 15, 2020.RESULTSOf approximately 400 followed at our institution, 22 acquired COVID-19. Clinical characteristics included median age 59 (range, 49–71) years,...

10.1016/j.healun.2020.06.015 article EN other-oa The Journal of Heart and Lung Transplantation 2020-06-25

Left ventricular assist device (LVAD)–specific infections (LSIs) are common in patients on LVAD support awaiting heart transplant (HT), yet their impact post-HT outcomes is not completely understood. We hypothesized that LSIs would result vasoplegia and negatively affect 30-day 1-year outcomes. LSI was defined as driveline, pump, or pocket infection. The short-term outcome a composite of acute renal failure, allograft rejection, mortality at 30 days after HT. long-term rejection death within...

10.1016/j.amjcard.2021.08.044 article EN cc-by-nc-nd The American Journal of Cardiology 2021-10-04
Coming Soon ...